Key result
IV granisetron is linked to transient QT dispersion and reduced heart rate, unlike ondansetron.
Why the study?
The cardiac safety and effects on electrocardiography of granisetron and ondansetron have not been investigated in children receiving chemotherapy for acute leukemia.
Does intravenous ondansetron or granisetron cause electrocardiographic changes in children receiving chemotherapy for acute leukemia?
Observational (n=22)
Does intravenous ondansetron or granisetron cause electrocardiographic changes in children receiving chemotherapy for acute leukemia?
Answers are grounded in this paper and cite their sources.
Intravenous granisetron, but not ondansetron, causes transient and asymptomatic ECG changes including QT/QTc prolongation in children receiving chemotherapy.
5-HT3 receptor antagonists, including granisetron and ondansetron, are widely used in the prophylactic treatment of chemotherapy-induced nausea and vomiting. Although the cardiac safety of granisetron and ondansetron has been investigated in several adult studies, there is no report investigating the effects of those agents on electrocardiography (ECG) in children. The effects of intravenously infused (over 30 seconds) 0.1 mg/kg ondansetron and 40 microg/kg granisetron on ECG were assessed in 22 children receiving high-dose methotrexate therapy for acute lymphoblastic leukemia. The ECG recording was obtained at before and just after the infusion, and repeated at 1, 3, 6, and 24 hours of treatment. Granisetron administration resulted in a statistically significant decrease of mean heart rate at 1 and 3 hours, and significant prolongation of mean QT and QTc dispersions at 1 hour of infusion. In patients treated with ondansetron, no meaningful change was observed. In conclusion, intravenous granisetron but not ondansetron causes clinically asymptomatic and transient changes on ECG measurements in children receiving high-dose methotrexate therapy.
No takes yet. Share an insight, caveat, or question.
Büyükavcı et al. (2005) conducted an observational in Acute lymphoblastic leukemia (n=22). Ondansetron and Granisetron vs. Baseline (pre-infusion) was evaluated on Electrocardiography (ECG) changes including heart rate, QT, and QTc dispersions. Intravenous granisetron, but not ondansetron, caused significant but clinically asymptomatic and transient decreases in heart rate and prolongations of QT and QTc dispersions.
Synapse has enriched 10 related papers. Consider them for comparative context: